Point72 Middle East FZE’s Pfizer PFE Stock Holding History

Point72 Middle East FZE’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-166,900	Closed	-$4.81M	–	976
2023 Q4	$4.81M	Sell	166,900 -61,100	-27%	-$1.85M	0.14%	186
2023 Q3	$7.56M	Buy	228,000 +11,400	+5%	+$403K	0.25%	99
2023 Q2	$7.94M	Sell	216,600 -141,300	-39%	-$5.5M	0.22%	108
2023 Q1	$14.6M	Buy	357,900 +338,800	+1,774%	+$14.6M	0.5%	36
2022 Q4	$979K	Buy	+19,100	New	+$916K	0.04%	512

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Point72 Middle East FZE's PFE Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Pfizer (PFE) in Q1 2024, closing a stake of 66,500 shares — an estimated $1.91M sold.

Point72 Middle East FZE first reported a position in PFE in Q1 2023 and held it in 2 quarters. The position peaked at $1.91M in Q4 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Point72 Middle East FZE reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 66,500 Pfizer shares in Q1 2024, an estimated $1.91M.
Point72 Middle East FZE first reported a position in Pfizer in Q1 2023 and held it in 2 quarters.
Point72 Middle East FZE's Pfizer position peaked at $1.91M in Q4 2023.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.